959 Folgen

  1. Financials: Yield Traps: When Dividends Sound Too Good To Be True

    Vom: 30.4.2018
  2. Tech: Facebook is Back on Track

    Vom: 27.4.2018
  3. Energy: Can Alaska Air Group Rebound From Its Fall From Grace

    Vom: 26.4.2018
  4. Healthcare: GW Pharma Poised for First FDA Marijuana Approval

    Vom: 25.4.2018
  5. CG: Expand Your Investing Universe With Stock Screeners

    Vom: 24.4.2018
  6. Financials: A Trio of Financial Sector Headlines

    Vom: 23.4.2018
  7. Tech: 3 Small Tech Stocks To Watch

    Vom: 23.4.2018
  8. Energy: Will China’s Intelligent Highway Pave the Way to the Future

    Vom: 19.4.2018
  9. Healthcare: A Surprising Reversal for Alkermes, Celldex's Super Bad News, and J&J's Q1 in Review

    Vom: 18.4.2018
  10. CG: Dissecting a “Weak” Year for Ulta Beauty

    Vom: 17.4.2018
  11. Financials: Breaking Down Big Bank Earnings

    Vom: 16.4.2018
  12. Tech: What Would You Pay for Facebook?

    Vom: 13.4.2018
  13. Energy: Two Tumultuous Stocks – Are They Still Buys?

    Vom: 12.4.2018
  14. Healthcare: What Was Biogen Thinking?

    Vom: 11.4.2018
  15. CG: Estee Lauder Stock Surges on the Back of Prestige Branding

    Vom: 10.4.2018
  16. Financials: 3 Financial Sectors Vertically Integrating

    Vom: 9.4.2018
  17. Tech: Spotify's Hot Start

    Vom: 6.4.2018
  18. Energy: Saudi Arabia Is Holding the World’s Biggest Solar Party

    Vom: 5.4.2018
  19. Healthcare: Will Shire Be Bought Out? Plus, Alkermes Suffers a Setback

    Vom: 4.4.2018
  20. CG: ADT Suffers a Rocky Start to 2018

    Vom: 3.4.2018

47 / 48

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at [email protected].

Visit the podcast's native language site